Humana Low Level Laser Therapy and High Power Laser Therapy - Medicare Advantage Form
Procedure is not covered
Please refer to CMS website for the most current applicable National Coverage Determination (NCD)/
Local Coverage Determination (LCD)/Local Coverage Article (LCA)/CMS Online Manual
System/Transmittals.
Type
Title
ID
Number
Jurisdiction
Medicare
Administrative
Contractors (MACs)
Applicable
States/Territories
LCD
LCA
LCD
LCA
Outpatient Physical and
Occupational Therapy Services
L33631
Billing and Coding: Outpatient
Physical and Occupational
Therapy Services
A56566
Outpatient Physical and
Occupational Therapy Services
L34049
Billing and Coding: Outpatient
Physical and Occupational
Therapy Services
A57067
Low Level Laser and High Power Laser Therapy
Page: 2 of 7
J6 - National
Government
Services, Inc. (Part
A/B MAC)
JK - National
Government
Services, Inc. (Part
A/B MAC
IL, MN, WI
CT, NY, ME, MA, NH,
RI, VT
J15 - CGS
Administrators, LLC
(Part A/B MAC)
KY, OH
Description
Low Level Laser Therapy
Low level laser therapy (LLLT), also known as cold laser or photobiomodulation therapy, refers to a wide
variety of procedures involving several laser types and treatment methods. LLLT uses red beam or near
infrared nonthermal lasers. When applied, the lasers penetrate the surface of the skin without a heating
(burning) effect, produce no sensation and do not damage the skin. Purportedly due to the low skin
absorption and no side effects, the laser light can penetrate deeply into tissues and reach the site of
damage or injury.
LLLT may be administered by a physician, physical therapist, occupational therapist or Doctor of
Chiropractic (DC) in a provider’s office or other outpatient setting and requires no sedation or anesthesia. It
is theorized that LLLT may cause a biostimulatory healing effect for the treatment of a range of conditions,
including alopecia, arthritis, carpal tunnel syndrome, chronic pain, prevention of oral mucositis,
temporomandibular joint disorders, tissue injuries (eg, tendinopathy, tendinitis) and wound healing. These
devices are not the same as (or equivalent to) class IV surgical lasers.
Examples of LLLT devices include, but may not be limited to, Bioptron 2, Bioptron MedAll, Bioptron Pro 1,
Erchonia EVRL, Erchonia FX-635, Luminex Laser Therapy System, MicroLight ML830, RianCorp LTU-904,
TerraQuant, Thor Laser System and Willow Curve. The TerraQuant device uses a combination of a super
pulsed laser, pulsed infrared, red light and static magnetic field, which is purported to accelerate pain relief.
The Willow Curve primarily uses dual dynamic photonic and dynamic thermokinetic energies proposed for
treating musculoskeletal pain.
High Power Laser Therapy
High power laser therapy devices, also referred to as high dose laser therapy (HDLT) or high intensity laser
therapy (HILT), (class IV therapeutic lasers) are purported to stimulate accelerated healing energy from
Low Level Laser and High Power Laser Therapy
Page: 3 of 7
superficial to deep levels (six to nine inches) over a larger surface treatment area. It is proposed for treating
conditions such as arthritis, carpal tunnel syndrome, chronic pain, epicondylitis, sprains/strains, trigger
points and various other musculoskeletal disorders. These devices are not the same as (or equivalent to)
class IV surgical lasers.
Examples of high power laser therapy devices that have received US Food & Drug Administration (FDA)
approval are the AVI HP-7.5, AVI HPLL-12 and Diowave Laser System.
Coverage Determination
Humana follows the CMS requirements that only allows coverage and payment for services that are
reasonable and necessary for the diagnosis and treatment of illness or injury or to improve the functioning
of a malformed body member except as specifically allowed by Medicare.
Coverage Limitations
US Government Publishing Office. Electronic code of federal regulations: part 411 – 42 CFR § 411.15 -
Particular services excluded from coverage
Low level laser therapy will not be considered medically reasonable and necessary.
A review of the current medical literature shows that the evidence is insufficient to determine that this
service is a standard medical treatment. There remains an absence of randomized, blinded clinical studies
examining benefit and long-term clinical outcomes establishing the value of this service in clinical
management.3,4
High level laser therapy (nonsurgical) will not be considered medically reasonable and necessary.
A review of the current medical literature shows that the evidence is insufficient to determine that high
power laser therapy (nonsurgical) is a standard medical treatment. There remains an absence of
randomized, blinded clinical studies examining benefit and long-term clinical outcomes establishing the
value of this service in clinical management
Summary of Evidence
A systematic review (SR) with meta-analyses of nine randomized controlled trials (RCTs) and eight
additional RCTs (not included in the SR) found that HILT alone or in combination with other treatments may
reduce pain and improve function up to three months in some patients with chronic neck or back pain, the
studies assessed too few patients per comparison and too few patients per pain etiology, and most studies
include few patients. Additional studies are needed to confirm findings.5
Low Level Laser and High Power Laser Therapy
Page: 4 of 7
A systematic review (SR) with meta-analysis of six randomized controlled trials (RCTs) and 1 additional RCT
indicate that HILT alone or in combination with other treatments may reduce pain and improve function in
some patients with knee OA up to three months after treatment, most studies in the SR are at high risk of
bias and have high heterogeneity; additional RCTs are needed to validate these data.6